This month proved something we already know to be true, your biggest resource is your community. This month at FITCI was a demonstration of what a strong business community can look like: companies supporting each other, sharing what they know, and creating opportunities to be seen. These moments are a reminder that being part of … Read more
Bioscience
With the 2026 Tech Showcase fast approaching we are spotlighting FITCI companies leading up to it. Follow along to learn more about the companies featured in this years Tech Showcase, and the groundbreaking technology, research, and science happening in right here in Frederick. For Anindya Chanda, CEO of Mycologics, fungi have been the focus of … Read more
In June 2024, BioEvanesce established its laboratory at FITCI, Frederick’s leading incubator for life sciences and technology startups. The company is on a mission to tackle a pervasive and often overlooked post-surgical complication that affects millions of patients each year: Scar Tissue Adhesions. “Adhesions are the bane of surgeons’ existence,” says BioEvanesce founder, Erin Evke, a PhD … Read more
Experience the Future in Every Dimension at FITCI’s spectacular launch celebration of Maryland’s EDGE at 321 Ballenger Center Drive in Frederick, Maryland. Join the journey into the future of innovation in Frederick as we unveil our brand-new space designed to inspire innovation, collaboration, and breakthrough discoveries. Highlights include lots of surprises, and tours of our … Read more
FITCI begins transition to new facility, offers community tours Rounding into phase 1 completion of the area’s newest entrepreneurial community space at the EDGE at 321, FITCI achieved move-in approval this month. As part of the transition, startup leaders & potential resource partners can get an exclusive preview. The facility offers state-of-the-art private & shared … Read more
CarrTech Corporation performed its human factor trials with local healthcare professionals at FITCI’s Metropolitan Court location May 17th through 28th, moving their all-in-one package filter and hypodermic needle product, F.R.O.G (filter removal of glass), closer to market. This practical testing enlisted 20 study participants with experience using glass ampoule-based medications (i.e., #physicians, #pharmacists, #nurses). The … Read more
Sam Glickstein, CEO of FITCI client Osprey BioScience, announced that the company officially launched their flagship product – CloneCard. The patent-pending item is a proprietary nucleic acid storage and delivery (at room temperature) system. It offers researchers the ability to start building multi-genic and multi-modal therapeutic candidates modularly, in less time and with lower costs. … Read more
Congratulations #FITCI Grad Theradaptive on your ICON Award win! The Maryland Tech Council, the largest technology and life science trade association in the state, announced the winners of its 2023 ICON Awards on April 28, 2023, hailing Frederick’s own Theradaptive as its “Emerging Life Sciences Company of the Year.” Kelly Schulz, CEO of the Maryland … Read more
Sixty-five CEOs from innovative, fast-growing companies were selected to participate in the invitation-only program. WASHINGTON (PRWEB) April 03, 2023 Mindshare, an exclusive organization designed for CEOs of the most promising, disruptive technology and product companies in the Washington, DC metropolitan area, announces the members of its 2023 class. Founded in 1997 with the mission to … Read more
The paper, which debuted on March 26, 2023, chronicles the history of the development of epinephrine dosing. The 0.3mg dose of epinephrine is currently used to treat patients suffering from anaphylaxis. The article is credited to Peyton Coady, BS, Kenneth L. Dretchen, PhD, and Michael Mesa. Read the full piece here: https://journals.sagepub.com/doi/10.1177/27534030231161784 Founder and CEO … Read more
